Gastrointestinal Disorders :
Explore Genetic Insights
Summary
Diseases Found | 46 |
High Risk | 1 |
Medium Risk | 43 |
Low Risk | 2 |
Mutated Genes Found | 21 |
Contents
- Autoimmune Disorders Page 1
- Brain Health (Neurological Disorders) Page 2
- Cancers (Neoplastic Diseases) Page 3
- Dermatological Diseases Page 4
- Endocrine Disorders Page 5
- Gastrointestinal Disorders Page 6
- Genitourinary Disorders Page 7
- Heart Health (Cardiovascular Diseases) Page 8
- Hematological Disorders Page 9
- Metabolic Disorders Page 10
- Musculoskeletal Diseases Page 11
- Obstetric and Gynecological Disorders Page 12
- Ophthalmological Diseases Page 13
- Appendix
Gastrointestinal Disorders :
The following diseases are associated with Gastrointestinal Disorders ::
Disease | Predisposition |
---|---|
Digestive System Diseases | Medium |
Gastrointestinal Diseases | Medium |
Intestinal Diseases | Medium |
Digestive System Diseases
Auditory system diseases can vary widely in their genetic transmission. Some common types of genetic inheritance patterns for these conditions include: 1. **Autosomal Dominant**: A single copy of the altered gene in each cell is sufficient to cause the disorder. 2. **Autosomal Recessive**: Two copies of the altered gene, one from each parent, are necessary to cause the disorder. 3. **X-linked Recessive**: The gene causing the condition is located on the X chromosome. Males are more frequently affected as they have one X and one Y chromosome. 4. **Mitochondrial Inheritance**: The gene causing the disorder is located in mitochondrial DNA, and the condition is typically passed from mother to child. These patterns can be observed in various diseases affecting the auditory system, including certain forms of deafness and auditory neuropathy.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
GTPBP8 | Deletion | C/A | High |
ACAD9-DT | Substitution | G/A | Medium |
GRM6 | Frameshift | A/T | Medium |
MRPL36 | Inversion | C/A | Medium |
FOXD4 | Deletion | T/C | High |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
GTPBP8 | 24% |
ACAD9-DT | 5% |
GRM6 | 22% |
MRPL36 | 8% |
FOXD4 | 22% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-74160 | NF-kappa B Signaling Pathway | Influences inflammatory response |
REACT:R-HSA-76002 | Adrenergic Receptor Signaling | Regulates neurotransmitter release |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
GTPBP8 | Depression | Neurodegeneration |
ACAD9-DT | Asthma | Chronic infection |
GRM6 | Depression | Genetic predisposition |
MRPL36 | Depression | Inflammation |
FOXD4 | Depression | Neurodegeneration |
Recommendations for Medium Risk for Auditory System Disease
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for digestive system diseases.
Gastrointestinal Diseases
The type of genetic transmission for gastrointestinal system diseases can vary based on the specific condition. Some gastrointestinal diseases are inherited in an autosomal dominant or autosomal recessive manner, while others might follow X-linked or multifactorial inheritance patterns. For instance, Familial Adenomatous Polyposis (FAP) is typically inherited in an autosomal dominant manner, while some forms of monogenic inflammatory bowel disease (IBD) may follow an autosomal recessive inheritance.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
LRPPRC | Deletion | C/A | Medium |
FOXD4 | Substitution | A/C | High |
GTPBP8 | Insertion | C/T | Medium |
SDHA | Insertion | C/G | High |
MRPL36 | Insertion | A/G | Medium |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
LRPPRC | 8% |
FOXD4 | 1% |
GTPBP8 | 7% |
SDHA | 22% |
MRPL36 | 9% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-74160 | mTOR Signaling Pathway | Involved in cell growth and survival |
REACT:R-HSA-76002 | MAPK Signaling Pathway | Affects immune response |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
LRPPRC | Osteoporosis | Mitochondrial impairment |
FOXD4 | Chronic Obstructive Pulmonary Disease (COPD) | Oxidative stress |
GTPBP8 | Osteoporosis | Cellular apoptosis |
SDHA | Asthma | Hormonal imbalance |
MRPL36 | Hypertension | Inflammation |
Recommendations for Medium Risk for Gastrointestinal System Disease
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for Gastrointestinal Diseases.
Intestinal Diseases
Intestinal diseases can be broadly classified into various types, including infectious (e.g., bacterial, viral, parasitic), inflammatory (e.g., Crohn's disease, ulcerative colitis), functional (e.g., irritable bowel syndrome), and structural (e.g., bowel obstruction). Type of genetic transmission varies; some intestinal diseases have genetic components. For example, Crohn's disease and ulcerative colitis, both types of inflammatory bowel disease (IBD), can have a hereditary predisposition. The genetic transmission is typically multifactorial, involving multiple genes and environmental factors rather than following a simple Mendelian inheritance pattern.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
FOXD4 | Insertion | C/A | High |
GTPBP8 | Inversion | G/A | High |
ZDHHC11 | Insertion | G/C | Medium |
ZNF518B | Substitution | A/C | Medium |
MRPL36 | Inversion | C/T | High |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
FOXD4 | 22% |
GTPBP8 | 18% |
ZDHHC11 | 18% |
ZNF518B | 12% |
MRPL36 | 12% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-74160 | Hedgehog Signaling Pathway | Impacts cellular stress response |
REACT:R-HSA-76002 | TGF-beta Signaling Pathway | Critical for embryonic development |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
FOXD4 | Asthma | Chronic infection |
GTPBP8 | Chronic Obstructive Pulmonary Disease (COPD) | Chronic infection |
ZDHHC11 | Osteoporosis | Mitochondrial impairment |
ZNF518B | Diabetes | Inflammation |
MRPL36 | Diabetes | Inflammation |
Recommendations for Medium Risk for Intestinal Disease
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for Intestinal Diseases.
Appendix
Mutated Genes Found
Gene | Associated Diseases | Chromosome Position |
---|---|---|
SLC12A7 |
|
Chr19:49583707 |
ANK2 |
|
Chr8:44182806 |
ZFYVE9 |
|
Chr8:35686144 |
FOXD4 |
|
Chr14:89772375 |
ACAD9-DT |
|
ChrX:88890565 |
PUM3 |
|
Chr19:78258062 |
MRPL36 |
|
Chr6:88642158 |
GSTM4 |
|
Chr11:11420919 |
TMEM45A |
|
Chr7:46816927 |
ZDHHC11 |
|
Chr21:42574895 |
ZNF518B |
|
Chr13:89715390 |
GTPBP8 |
|
Chr10:34356769 |
PHACTR2 |
|
Chr22:48581173 |
MROH2B |
|
Chr19:14197859 |
GRM6 |
|
Chr3:70226829 |
NQO2 |
|
Chr3:52208640 |
SDHA |
|
Chr4:49814112 |
ACAD9 |
|
Chr5:86498925 |
LRPPRC |
|
Chr3:26163502 |
ACTN2 |
|
Chr21:27147199 |
FAM110C |
|
ChrY:98064611 |
Diseases Found
Disease | Category | Predisposition |
---|---|---|
immune system diseases | Autoimmune Disorders : | Medium |
Autoimmune Diseases | Autoimmune Disorders : | Medium |
Connective Tissue Diseases | Autoimmune Disorders : | Low |
demyelinating autoimmune diseases, cns | Autoimmune Disorders : | Low |
Alzheimer Disease | Brain Health (Neurological Disorders) | High |
Nervous System Diseases | Brain Health (Neurological Disorders) | Medium |
Neurodegenerative Diseases | Brain Health (Neurological Disorders) | Medium |
Cerebrovascular Disorders | Brain Health (Neurological Disorders) | Medium |
central nervous system diseases | Brain Health (Neurological Disorders) | Medium |
brain diseases, metabolic | Brain Health (Neurological Disorders) | Medium |
neuromuscular diseases | Brain Health (Neurological Disorders) | Medium |
lysosomal storage diseases, nervous system | Brain Health (Neurological Disorders) | Medium |
neurologic manifestations | Brain Health (Neurological Disorders) | Medium |
cranial nerve diseases | Brain Health (Neurological Disorders) | Medium |
Spinal Cord Ischemia | Brain Health (Neurological Disorders) | Medium |
genital neoplasms, male | Cancers (Neoplastic Diseases) | Medium |
Prostatic Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Breast Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Gastrointestinal Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Digestive System Neoplasms | Cancers (Neoplastic Diseases) | Medium |
skin and connective tissue diseases | Dermatological Diseases : | Medium |
Endocrine System Diseases | Endocrine Disorders : | Medium |
digestive system diseases | Gastrointestinal Disorders : | Medium |
Gastrointestinal Diseases | Gastrointestinal Disorders : | Medium |
Intestinal Diseases | Gastrointestinal Disorders : | Medium |
Male Urogenital Diseases | Genitourinary Disorders : | Medium |
Cardiovascular Abnormalities | Heart Health (Cardiovascular Diseases) | Medium |
Cardiomyopathy, Hypertrophic | Heart Health (Cardiovascular Diseases) | Medium |
Vascular Diseases | Heart Health (Cardiovascular Diseases) | Medium |
Hypertension | Heart Health (Cardiovascular Diseases) | Medium |
Coronary Artery Disease | Heart Health (Cardiovascular Diseases) | Medium |
hemic and lymphatic diseases | Hematological Disorders : | Medium |
Hematologic Diseases | Hematological Disorders : | Medium |
Blood Coagulation Disorders | Hematological Disorders : | Medium |
Hemorrhagic Disorders | Hematological Disorders : | Medium |
Thrombophilia | Hematological Disorders : | Medium |
carbohydrate metabolism, inborn errors | Metabolic Disorders : | Medium |
lipid metabolism disorders | Metabolic Disorders : | Medium |
lipidoses | Metabolic Disorders : | Medium |
Obesity | Metabolic Disorders : | Medium |
Diabetes Mellitus, Type 1 | Metabolic Disorders : | Medium |
Lipid Metabolism, Inborn Errors | Metabolic Disorders : | Medium |
musculoskeletal diseases | Musculoskeletal Diseases : | Medium |
Muscular Diseases | Musculoskeletal Diseases : | Medium |
female urogenital diseases and pregnancy complications | Obstetric and Gynecological Disorders : | Medium |
female urogenital diseases and pregnancy complications | Ophthalmological Diseases : | Medium |